Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Noven and Novartis establish joint venture to promote Vivelle

May 6, 1998

Sanguine funds development of blood substitute

May 6, 1998

Generex completes proof-of-concept trials with oral insulin

May 5, 1998

Harvard Scientific unveils new treatment for female sexual dysfunction

May 5, 1998

New antidiabetic agent in the pipeline at Sumitomi Metal

May 5, 1998

HMG-CoA reductase inhibition upregulates ecNOS expression in vitro

May 5, 1998

BRL-49653 may mediate insulin sensitivity by reducing FFA release from adipocytes

May 5, 1998

FDA advisory committee votes against approval of tocolytic

May 4, 1998

Another statin approved for stroke prevention indications

May 4, 1998

Novel diabetes collaboration formed by OSI and Vanderbilt University

May 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...